Physician profile
John C Macy
NPI 1225062110
$245,284.63
in general payments reported to CMS, 2019-2025
8 companies · $118K in 2025
The $118K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $212 · 2020: $868 · 2021: $766 · 2022: $8,509 · 2023: $33K · 2024: $84K · 2025: $118K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $156K · Consulting Fee: $57K · Travel and Lodging: $18K · Food and Beverage: $2,921 · Gift: $561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $156,285.45 |
| Consulting Fee | $56,750.00 |
| Travel and Lodging | $18,412.62 |
| Food and Beverage | $2,920.62 |
| Gift | $561.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shoulder Innovations, INC. | $243,239.68 | 2020-2025 | Inset System |
| Zurimed Technologies INC. | $977.81 | 2025 | Fiberlocker System |
| Prodigy Surgical Distribution, INC. | $397.53 | 2023 | |
| Arthrex, INC. | $278.08 | 2023 | |
| Wright Medical Technology, INC. | $229.97 | 2019-2020 | |
| Encore Medical, Lp | $71.98 | 2019 | |
| Depuy Synthes Sales INC. | $58.17 | 2023 | Dynacord, N/A |
| Coopersurgical, INC. | $31.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Macy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.